A daily pill just doubled survival time for advanced pancreatic cancer
BY THE OPTIMIST DAILY EDITORIAL TEAM In a 500-patient trial at American Society of Clinical Oncology’s (ASCO) annual meeting in Chicago, a daily pill called daraxonrasib doubled average survival time in patients with advanced pancreatic cancer. Those on the drug lived for an aver
Jun 3, 2026Positivity +60
BY THE OPTIMIST DAILY EDITORIAL TEAM In a 500-patient trial at American Society of Clinical Oncology’s (ASCO) annual meeting in Chicago, a daily pill called daraxonrasib doubled average survival time in patients with advanced pancreatic cancer. Those on the drug lived for an aver
This good news was originally reported by The Optimist Daily. We curate and add context — they did the reporting.
Read the full story at the source →More good news
Armed With UK Degree, Bhopal Boy Aims to Power an Avocado Farming Revolution
The Better India · Jul 7, 2026